125 related articles for article (PubMed ID: 3341058)
1. Infection with hepatitis delta and human immunodeficiency viruses among hemophiliacs in Japan.
Inagaki M; Miura T; Taki M; Saito N; Yamada K; Unuma T; Tsuda F; Miyakawa Y; Mayumi M
Transfusion; 1988; 28(1):18-20. PubMed ID: 3341058
[TBL] [Abstract][Full Text] [Related]
2. Delta infection and liver disease in hemophilic carriers of hepatitis B surface antigen.
Rizzetto M; Morello C; Mannucci PM; Gocke DJ; Spero JA; Lewis JH; Van Thiel DH; Scaroni C; Peyretti F
J Infect Dis; 1982 Jan; 145(1):18-22. PubMed ID: 7033398
[TBL] [Abstract][Full Text] [Related]
3. Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study.
Rosina F; Saracco G; Rizzetto M
N Engl J Med; 1985 Jun; 312(23):1488-91. PubMed ID: 3990749
[TBL] [Abstract][Full Text] [Related]
4. [Delta agent in hemophiliacs in Japan--with special reference to hepatitis B virus and HTLV-III/LAV].
Miura T; Inagaki M; Taki M; Tomita Y; Saito N; Yamada K; Ise I; Tsuda F
Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1427-31. PubMed ID: 3825459
[No Abstract] [Full Text] [Related]
5. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs.
Ghany MG; Leissinger C; Lagier R; Sanchez-Pescador R; Lok AS
Dig Dis Sci; 1996 Jun; 41(6):1265-72. PubMed ID: 8654162
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of human immunodeficiency virus (HIV) infection among hemophiliacs in Fukuoka, Japan.
Kashiwagi S; Hayashi J; Ikematsu H; Noguchi A; Ikeda K; Kishida K; Shirakawa M; Takenaka A; Mori R
Microbiol Immunol; 1988; 32(8):851-5. PubMed ID: 3143898
[TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
Amini S; Mahmoodi MF; Andalibi S; Solati AA
J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis delta infection among multiply-transfused hemophiliacs.
Lemon SM; Becherer PR; Wang JG; White GC; Lesesne H; Janco RL; Hanna WT; Davis C; Johnson CA; Poon MC
Prog Clin Biol Res; 1991; 364():351-60. PubMed ID: 2020710
[No Abstract] [Full Text] [Related]
9. [Delta agent infection in hemophilia].
Miura T; Inagaki M
Rinsho Byori; 1987 Sep; Spec No 73():74-8. PubMed ID: 3437535
[No Abstract] [Full Text] [Related]
10. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C.
Eyster ME; Sanders JC; Battegay M; Di Bisceglie AM
Dig Dis Sci; 1995 Jul; 40(7):1583-8. PubMed ID: 7628288
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C infection in children with hemophilia A and B.
Blanchette VS; Vorstman E; Shore A; Wang E; Petric M; Jett BW; Alter HJ
Blood; 1991 Jul; 78(2):285-9. PubMed ID: 1712646
[TBL] [Abstract][Full Text] [Related]
12. HTLV III antibodies and immunological alterations in hemophilia patients.
Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.
Schulman S; Wiechel B
Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
Rizzetto M; Purcell RH; Gerin JL
Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036
[TBL] [Abstract][Full Text] [Related]
15. [Study of serological and biological markers in viral hepatitis. 157 hemophiliacs].
Parquet-Gernez A; Boulanger-Fasquelle P; Maniez-Montreuil M; Goudemand M
Rev Fr Transfus Immunohematol; 1981 Nov; 24(5):463-82. PubMed ID: 6798669
[TBL] [Abstract][Full Text] [Related]
16. Delta hepatitis in Malaysia.
Sinniah M; Dimitrakakis M; Tan DS
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of hepatitis-B antigen (HB S Ag) and its antibody (Anti-HB S) among London hemophiliacs and blood donors from London and two tropical areas.
Islam MN; Banatvala JE
Transfusion; 1976; 16(3):237-41. PubMed ID: 936273
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran).
Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R
Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038
[TBL] [Abstract][Full Text] [Related]
19. Concurrent hepatitis B, delta and human immunodeficiency virus infection in hemophiliacs.
Hatzakis A; Hadziyannis S; Maclure M; Louizou C; Yannitsiotis A; Mandalaki T
Thromb Haemost; 1987 Aug; 58(2):791. PubMed ID: 3672432
[No Abstract] [Full Text] [Related]
20. Immunodeficiency in patients with hemophilia: an underlying deficiency and lack of correlation with factor replacement therapy or exposure to human immunodeficiency virus.
Jin ZW; Cleveland RP; Kaufman DB
J Allergy Clin Immunol; 1989 Jan; 83(1):165-70. PubMed ID: 2913135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
